NTBL Insider Trading

Insider Ownership Percentage: 1.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $126,441.13

Notable Labs Insider Trading History Chart

This chart shows the insider buying and selling history at Notable Labs by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Notable Labs Share Price & Price History

Current Price: $0.96
Price Change: Price Decrease of -0.01 (-1.03%)
As of 05/22/2024 05:00 PM ET

This chart shows the closing price history over time for NTBL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Notable Labs Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/2/2024Fr Capital Holdings, L.P.Major ShareholderSell50,000$1.89$94,500.00880,489View SEC Filing Icon  
12/26/2023Fr Capital Holdings, L.P.Major ShareholderSell11,456$2.16$24,744.96978,022View SEC Filing Icon  
12/21/2023Fr Capital Holdings, L.P.Major ShareholderSell2,867$2.51$7,196.171,034,478View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Notable Labs (NASDAQ:NTBL)

70.48% of Notable Labs stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Notable Labs Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/6/2024Industry Ventures L.L.C.204,424$0.39M0.6%N/A9.208%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Notable Labs logo
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.
Read More on Notable Labs

Today's Range

Now: $0.96
Low: $0.92
High: $0.99

50 Day Range

MA: $1.30
Low: $0.91
High: $1.91

52 Week Range

Now: $0.96
Low: $0.83
High: $11.20

Volume

68,994 shs

Average Volume

346,288 shs

Market Capitalization

$2.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Who are the company insiders with the largest holdings of Notable Labs?

Notable Labs' top insider shareholders include:
  1. Fr Capital Holdings, LP (Major Shareholder)
Learn More about top insider investors at Notable Labs.